Furthermore, HSP90 interacts with and inhibits the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the rate-limiting enzyme of mevalonate pathway that is essential for cancer progression [74]. The gene discussed is HSP90AB1; the disease is cancer.